STOCK TITAN

BlackRock Health Sciences Stock Price, News & Analysis

BME NYSE

Company Description

Blackrock Health Sciences Trust (BME) is a closed-end investment fund focused on the finance and insurance sector, within the securities and commodity exchanges industry. According to its stated investment objective, the trust seeks to provide total return through a combination of current income, current gains, and long-term capital appreciation. It does this by investing primarily in equity securities of companies engaged in health sciences and related industries, as well as in equity derivatives.

The trust’s strategy, as described in available information, is to invest at least 80% of its total assets in equity securities of health sciences companies and related industries and in equity derivatives. This focus on health sciences means the portfolio is concentrated in businesses connected to healthcare and related fields, while the use of equity derivatives is intended to support the objective of generating current income, gains, and capital appreciation over time.

Investment Objective and Strategy

The core objective of Blackrock Health Sciences Trust is to generate a total return that combines:

  • Current income
  • Current gains
  • Long-term capital appreciation

To pursue this objective, the fund states that it invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and in equity derivatives. This approach aligns the trust with the performance and developments of the health sciences space, while also allowing it to use derivatives linked to equity markets as part of its strategy.

Sector and Industry Classification

For classification purposes on Stock Titan, Blackrock Health Sciences Trust is associated with the Finance and Insurance sector and the Securities and Commodity Exchanges industry. This reflects its structure as an investment vehicle whose shares trade in public markets and whose primary activity is investing in securities rather than producing or selling health-related products or services directly.

Health Sciences Focus

The trust’s emphasis on companies engaged in health sciences and related industries means its portfolio is tied to businesses operating in or around the broader healthcare ecosystem. While specific holdings are not detailed in the provided information, the mandate clearly links the fund’s investments to equity securities in that area and to equity derivatives connected to those markets.

Use of Equity Derivatives

Available information notes that Blackrock Health Sciences Trust invests in equity derivatives alongside equity securities. These instruments are used as part of the trust’s effort to achieve its stated objectives of current income, current gains, and long-term capital appreciation. The exact types of derivatives or strategies are not specified in the provided data, but their inclusion is a defined part of the investment approach.

Relationship to BlackRock

The trust carries the Blackrock name, indicating association with the broader BlackRock fund family. Separate news items describe BlackRock, Inc. as a fiduciary to investors and a provider of financial technology that helps people build savings by making investing easier and more affordable. However, the news materials focus on BlackRock at the corporate level and on other products and platforms, not on BME specifically, so they are best understood as general context about the sponsor brand rather than detailed information about this particular trust.

Trading and Investor Considerations

As an investment fund classified in the securities and commodity exchanges industry, Blackrock Health Sciences Trust is designed for investors who want exposure to health sciences and related industries through a professionally managed, exchange-traded vehicle. The fund’s objective and 80% investment policy are central reference points for understanding how it is intended to operate. Specific details such as current portfolio composition, distribution policy, or leverage, if any, are not provided in the available data and would need to be obtained from official fund documents.

Evergreen Characteristics

The elements that define Blackrock Health Sciences Trust in a durable way are its:

  • Stated objective of total return through current income, current gains, and long-term capital appreciation
  • Policy to invest 80% of total assets in equity securities of health sciences and related industries and in equity derivatives
  • Placement in the finance and insurance sector and securities and commodity exchanges industry

These characteristics describe the structural design of the trust rather than short-term performance or time-sensitive details, making them useful for long-term reference when researching the BME stock.

Stock Performance

$—
0.00%
0.00
Last updated:
+1.93%
Performance 1 year
$539.5M

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of BlackRock Health Sciences (BME)?

The current stock price of BlackRock Health Sciences (BME) is $41.7312 as of February 5, 2026.

What is the market cap of BlackRock Health Sciences (BME)?

The market cap of BlackRock Health Sciences (BME) is approximately 539.5M. Learn more about what market capitalization means .

What is Blackrock Health Sciences Trust (BME)?

Blackrock Health Sciences Trust (BME) is an investment fund associated with the finance and insurance sector and the securities and commodity exchanges industry. It is designed to invest primarily in equity securities of companies engaged in the health sciences and related industries, as well as in equity derivatives.

What is the investment objective of Blackrock Health Sciences Trust?

According to its stated mandate, the investment objective of Blackrock Health Sciences Trust is to provide total return through a combination of current income, current gains, and long-term capital appreciation.

How does Blackrock Health Sciences Trust invest its assets?

The trust states that it invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and in equity derivatives. This links its portfolio to health sciences businesses and to derivatives tied to equity markets.

Which sector and industry does BME belong to?

On Stock Titan, Blackrock Health Sciences Trust is classified in the Finance and Insurance sector and the Securities and Commodity Exchanges industry, reflecting its role as an investment vehicle whose main activity is investing in securities.

Does Blackrock Health Sciences Trust use derivatives?

Yes. Available information notes that Blackrock Health Sciences Trust invests in equity derivatives alongside equity securities. These derivatives form part of the fund’s approach to pursuing current income, current gains, and long-term capital appreciation.

Is Blackrock Health Sciences Trust focused solely on health sciences companies?

The trust’s stated policy is to invest 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and in equity derivatives. This means health sciences and related industries are central to its investment focus.

How does BME seek to generate returns for investors?

Blackrock Health Sciences Trust seeks to generate returns by combining current income and current gains with long-term capital appreciation. It pursues this objective through investments in equity securities of health sciences and related industries and through equity derivatives, as described in its investment policy.

Is Blackrock Health Sciences Trust part of the broader BlackRock fund family?

The trust carries the Blackrock name, indicating association with the wider BlackRock fund family. Separate news materials describe BlackRock, Inc. as a fiduciary to investors and a provider of financial technology, but these materials focus on the corporate parent rather than on BME specifically.